FDA Approves Florida for Prescription Drug Imports From Canada
The FDA announced its approval of the state of Florida for the agency’s drug importation program, which allows imports of prescription drugs from Canada if they reduce costs for U.S. consumers without imposing additional risks to the public (see 2009290018),…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
the FDA said in a news release Jan. 5. Under the program, Florida still must submit more drug-specific information for FDA approval, test the drugs it seeks to import and relabel the drugs to be consistent with FDA requirements. The program was approved for two years from the date of the first importation, the FDA said.